Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Re-expression of miR-200c suppresses proliferation, colony formation andin vivotumor growth of murine claudin-low mammary tumor cells
Robert A. Jones, Katrina L. Watson, Anthony Bruce, et al.
Oncotarget (2017) Vol. 8, Iss. 14, pp. 23727-23749
Open Access | Times Cited: 21

Showing 21 citing articles:

New emerging roles of microRNAs in breast cancer
Edna Ayerim Mandujano-Tinoco, Alfredo García-Venzor, Jorge Meléndez-Zajgla, et al.
Breast Cancer Research and Treatment (2018) Vol. 171, Iss. 2, pp. 247-259
Closed Access | Times Cited: 51
Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth
Dandan Zhang, Yue Li, Yue Xu, et al.
Oncogene (2018) Vol. 38, Iss. 7, pp. 1106-1120
Open Access | Times Cited: 35
Inhibition of miR‐200b/miR‐429 contributes to neuropathic pain development through targeting zinc finger E box binding protein‐1
Xuetao Yan, Ying Zhao, Xiaoli Cheng, et al.
Journal of Cellular Physiology (2017) Vol. 233, Iss. 6, pp. 4815-4824
Closed Access | Times Cited: 34
Research progress of Claudin-low breast cancer
Chenglong Pan, Anqi Xu, Xiaoling Ma, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
The miR-200b/200a/429 cluster prevents metastasis and induces dormancy in a murine claudin-low mammary tumor cell line
Katrina L. Watson, Robert A. Jones, Anthony Bruce, et al.
Experimental Cell Research (2018) Vol. 369, Iss. 1, pp. 17-26
Closed Access | Times Cited: 26
Angioregulatory microRNAs in breast cancer: Molecular mechanistic basis and implications for therapeutic strategies
Mohammad Hasan Soheilifar, Nastaran Masoudi-Khoram, Soheil Madadi, et al.
Journal of Advanced Research (2021) Vol. 37, pp. 235-253
Open Access | Times Cited: 20
Recent progress on the effects of microRNAs and natural products on tumor epithelial–mesenchymal transition
Shujin He, Chuqi Xiang, Yu Zhang, et al.
OncoTargets and Therapy (2017) Vol. Volume 10, pp. 3435-3451
Open Access | Times Cited: 20
Polycomb repressor complex 2 function in breast cancer (Review)
Courtney Martin, Roger A. Moorehead
International Journal of Oncology (2020)
Open Access | Times Cited: 16
The miR-200 family in normal mammary gland development
M. Roth, Roger A. Moorehead
BMC Developmental Biology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Angiogenesis regulation by microRNAs and long non-coding RNAs in human breast cancer
Zhi Xiong Chong, Swee Keong Yeap, Wan Yong Ho
Pathology - Research and Practice (2021) Vol. 219, pp. 153326-153326
Closed Access | Times Cited: 12
Nidogen 1 regulates proliferation and migration/invasion in murine claudin‑low mammary tumor cells
Rebecca Jagroop, Courtney Martin, Roger A. Moorehead
Oncology Letters (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Re-expression of miR-200s in claudin‐low mammary tumor cells alters cell shape and reduces proliferation and invasion potentially through modulating other miRNAs and SUZ12 regulated genes
K. Simpson, G. Conquer-Van Heumen, Katrina L. Watson, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 11
Overexpression of miR-200s inhibits proliferation and invasion while increasing apoptosis in murine ovarian cancer cells
R.J. Carter, Jim Petrik, Roger A. Moorehead
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0307178-e0307178
Open Access | Times Cited: 1
Unraveling the metastasis‐preventing effect of miR‐200c in vitro and in vivo
Bianca Köhler, E.M. BRIEGER, Tom Brandstätter, et al.
Molecular Oncology (2024)
Open Access | Times Cited: 1
Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification
Bianca Köhler, Sviatlana Dubovik, Elisa Hörterer, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5554-5554
Open Access | Times Cited: 4
Integrative analysis of copy number and gene expression data identifies potential oncogenic drivers that promote mammary tumor recurrence
Robert A. Jones, Roger A. Moorehead
Genes Chromosomes and Cancer (2018) Vol. 58, Iss. 6, pp. 381-391
Closed Access | Times Cited: 5
Transgenic overexpression of the miR-200b/200a/429 cluster inhibits mammary tumor initiation
Katrina L. Watson, Rui Yi, Roger A. Moorehead
Translational Oncology (2021) Vol. 14, Iss. 12, pp. 101228-101228
Open Access | Times Cited: 4
Role of microRNA in Endocrine Disruptor-Induced Immunomodulation of Metabolic Health
Nitya Shree, Zehuan Ding, Jodi A. Flaws, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1034-1034
Open Access | Times Cited: 3
Isolated Soy Protein Promotes Mammary Tumor Development Induced by the Type I Insulin-like Growth Factor Receptor in Transgenic Mice
Katrina L. Watson, Kristen Sauerzopf, Roger A. Moorehead
Nutrition and Cancer (2020) Vol. 73, Iss. 8, pp. 1340-1349
Open Access | Times Cited: 2
Unravelling the metastasis-preventing effect of miR-200cin vitroandin vivo
Bianca Köhler, E.M. BRIEGER, Tom Brandstätter, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Critical regulatory levels in tumor differentiation: Signaling pathways, epigenetics and non‐coding transcripts
Fatemeh Zolghadr, Babak Bakhshinejad, Sapir Davuchbabny, et al.
BioEssays (2021) Vol. 43, Iss. 5
Closed Access
Page 1

Scroll to top